PARP inhibition in UV-associated angiosarcoma preclinical models

PURPOSE: Angiosarcoma (AS) is a rare vasoformative sarcoma, with poor overall survival and a high need for novel treatment options. Clinically, AS consists of different subtypes, including AS related to previous UV exposure (UV AS) which could indicate susceptibility to DNA damage repair inhibition....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cancer Res Clin Oncol
Asıl Yazarlar: Weidema, Marije E., Desar, Ingrid M. E., Hillebrandt-Roeffen, Melissa H. S., van Erp, Anke E. M., Masuzawa, Mikio, Flucke, Uta E., van der Graaf, Winette T. A., Versleijen-Jonkers, Yvonne M. H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2021
Konular:
Original Article – Cancer Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310857/
https://ncbi.nlm.nih.gov/pubmed/34085099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-021-03678-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller